---
document_datetime: 2023-09-21 17:57:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/matever-epar-all-authorised-presentations_en.pdf
document_name: matever-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 7.5159196
conversion_datetime: 2025-12-14 21:51:23.469373
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Name    | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging             | Content (concentration)   | Package size   |
|-----------------|---------|------------|-----------------------|---------------------------|-----------------------|---------------------------|----------------|
| EU/1/11/711/001 | Matever | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 20 tablets     |
| EU/1/11/711/002 | Matever | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 30 tablets     |
| EU/1/11/711/003 | Matever | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 50 tablets     |
| EU/1/11/711/004 | Matever | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 60 tablets     |
| EU/1/11/711/005 | Matever | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 100 tablets    |
| EU/1/11/711/006 | Matever | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 200 tablets    |
| EU/1/11/711/007 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 10 tablets     |
| EU/1/11/711/008 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 20 tablets     |
| EU/1/11/711/009 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 30 tablets     |
| EU/1/11/711/010 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 50 tablets     |
| EU/1/11/711/011 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 60 tablets     |
| EU/1/11/711/012 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 100 tablets    |
| EU/1/11/711/013 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 120 tablets    |
| EU/1/11/711/014 | Matever | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 200 tablets    |
| EU/1/11/711/015 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 20 tablets     |
| EU/1/11/711/016 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 30 tablets     |
| EU/1/11/711/017 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 50 tablets     |
| EU/1/11/711/018 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 60 tablets     |
| EU/1/11/711/019 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 80 tablets     |
| EU/1/11/711/020 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 100 tablets    |
| EU/1/11/711/021 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 120 tablets    |
| EU/1/11/711/022 | Matever | 750 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 200 tablets    |
| EU/1/11/711/023 | Matever | 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 10 tablets     |
| EU/1/11/711/024 | Matever | 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 20 tablets     |
| EU/1/11/711/025 | Matever | 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 30 tablets     |
| EU/1/11/711/026 | Matever | 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 50 tablets     |
| EU/1/11/711/027 | Matever | 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 60 tablets     |
| EU/1/11/711/028 | Matever | 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 100 tablets    |
| EU/1/11/711/029 | Matever | 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC) |                           | 200 tablets    |
| EU/1/11/711/030 | Matever | 100 mg/ml  | Concentrate for       | Intravenous use           | vial (glass)          | 5 ml                      | 10 vials       |